What is the projected market valuation for the US bioresorbable scaffolds market by 2035?

The projected market valuation for the US bioresorbable scaffolds market is $800.0 Million by 2035. Read More

What was the market valuation for the US bioresorbable scaffolds market in 2024?

The market valuation for the US bioresorbable scaffolds market was $300.0 Million in 2024. Read More

What is the expected CAGR for the US bioresorbable scaffolds market during the forecast period 2025 - 2035?

The expected CAGR for the US bioresorbable scaffolds market during the forecast period 2025 - 2035 is 9.33%. Read More

Which application segment is projected to have the highest valuation in the US bioresorbable scaffolds market?

The Orthopedics and Cardiology application segments are projected to have the highest valuations, each ranging from $90.0 Million to $240.0 Million. Read More

What are the key materials used in bioresorbable scaffolds, and what are their projected valuations?

Key materials include Polylactic Acid ($90.0 Million to $240.0 Million), Polyglycolic Acid ($60.0 Million to $160.0 Million), and Polycaprolactone ($75.0 Million to $200.0 Million). Read More

Which technology segment is expected to dominate the US bioresorbable scaffolds market?

The Electrospinning technology segment is expected to dominate, with projected valuations ranging from $120.0 Million to $320.0 Million. Read More

What are the primary end-use segments for bioresorbable scaffolds in the US market?

Primary end-use segments include Hospitals ($120.0 Million to $320.0 Million) and Ambulatory Surgical Centers ($90.0 Million to $240.0 Million). Read More

Who are the key players in the US bioresorbable scaffolds market?

Key players in the US bioresorbable scaffolds market include Abbott, Baxter, Medtronic, Stryker, and Boston Scientific. Read More

What is the projected growth trend for the US bioresorbable scaffolds market from 2024 to 2035?

The US bioresorbable scaffolds market is projected to grow from $300.0 Million in 2024 to $800.0 Million by 2035. Read More

How does the market for bioresorbable scaffolds in the US compare across different applications?

The market for bioresorbable scaffolds in the US shows comparable valuations across applications, with Orthopedics and Cardiology leading, followed by Dental and Tissue Engineering, each ranging from $60.0 Million to $160.0 Million. Read More

US Bioresorbable Scaffolds Market

ID: MRFR/MED/17765-HCR

100 Pages

Nidhi Mandole

Last Updated: April 06, 2026

US Bioresorbable Scaffolds Market Research Report By Application (Orthopedics, Cardiology, Dental, Tissue Engineering), By Material Type (Polylactic Acid, Polyglycolic Acid, Polycaprolactone, Natural Polymers), By Technology (3D Printing, Electrospinning, Injection Molding) and By End Use (Hospitals, Ambulatory Surgical Centers, Research Laboratories) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Application (USD Million)
  1. 4.1.1 Orthopedics
  2. 4.1.2 Cardiology
  3. 4.1.3 Dental
  4. 4.1.4 Tissue Engineering
2. 4.2 Medical Device, BY Material Type (USD Million)
  1. 4.2.1 Polylactic Acid
  2. 4.2.2 Polyglycolic Acid
  3. 4.2.3 Polycaprolactone
  4. 4.2.4 Natural Polymers
3. 4.3 Medical Device, BY Technology (USD Million)
  1. 4.3.1 3D Printing
  2. 4.3.2 Electrospinning
  3. 4.3.3 Injection Molding
4. 4.4 Medical Device, BY End-Use (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Ambulatory Surgical Centers
  3. 4.4.3 Research Laboratories
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Baxter (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Medtronic (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Stryker (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Boston Scientific (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 DePuy Synthes (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Zimmer Biomet (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Evonik Industries (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 KLS Martin (DE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY MATERIAL TYPE
4. 6.4 US MARKET ANALYSIS BY TECHNOLOGY
5. 6.5 US MARKET ANALYSIS BY END-USE
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY MATERIAL TYPE, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY MATERIAL TYPE, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY TECHNOLOGY, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY END-USE, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY END-USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY MATERIAL TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US US Bioresorbable Scaffolds Market Segmentation

US Bioresorbable Scaffolds Market By Application (USD Million, 2025-2035)

Orthopedics
Cardiology
Dental
Tissue Engineering

US Bioresorbable Scaffolds Market By Material Type (USD Million, 2025-2035)

Polylactic Acid
Polyglycolic Acid
Polycaprolactone
Natural Polymers

US Bioresorbable Scaffolds Market By Technology (USD Million, 2025-2035)

3D Printing
Electrospinning
Injection Molding

US Bioresorbable Scaffolds Market By End-Use (USD Million, 2025-2035)

Hospitals
Ambulatory Surgical Centers
Research Laboratories

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”